NICOLE GOODIN: Open Payments
NPI 1336534437 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 60 payments from 16 companies in 2025. Trend: 2023 $1,011 · 2024 $789 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $235 |
| Axsome Therapeutics, Inc. | 7 | $176 |
| Otsuka America Pharmaceutical, Inc. | 6 | $97 |
| ABBVIE INC. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Sage Therapeutics, LLC | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Alkermes, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, Jornay PM, FANAPT, ZURZUVAE, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
